The present invention relates to prodrugs of pharmacologically active five-membered heterocyclic amidines from which are produced in vivo compounds which are competitive inhibitors of trypsin-like serine proteases, in particular thrombin and kininogenases such as kallikrein, to the preparation thereof and to the use thereof as medicines. The invention also relates to pharmaceutical compositions which comprise the prodrugs of the active compounds as ingredients, and to the use of the compounds as thrombin inhibitors, anticoagulants and as antiinflammatory agents.
本发明涉及药理活性的五元杂环
胺类前药,其中在体内产生的化合物是胰
蛋白酶类
丝氨酸蛋白酶的竞争性
抑制剂,特别是血栓素和激肽原酶,如激肽原酶,以及其制备和作为药物的用途。本发明还涉及包含活性化合物的前药的制药组合物,以及将这些化合物用作血栓素
抑制剂、抗凝剂和抗炎剂的用途。